Biogen Announces Topline Results from the Tofersen Phase 3 S

Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS

Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS

forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , American , Timothy Miller , Walter Gilbert , Charles Weissmann , Heinz Schaller , Alfred Sandrock Jr , Ashleigh Koss , Mike Hencke , Kenneth Murray , Head Of Research , Linkedin , Twitter , Ionis Pharmaceuticals Inc , Biogen Inc , Washington University School Of Medicine , Nasdaq , American Neurological Association , Exchange Commission , Youtube , Facebook , Media Snippet , Washington University School , Alfred Sandrock , Open Label Extension , Slow Vital Capacity , Neurological Association , Annual Meeting Presentation , Ionis Pharmaceuticals , Amyotrophic Lateral Sclerosis , Nobel Prize , Today Biogen , Private Securities Litigation Reform Act ,